ATE485047T1 - Verwendung eines wachstumsstimulierenden proteins - Google Patents

Verwendung eines wachstumsstimulierenden proteins

Info

Publication number
ATE485047T1
ATE485047T1 AT07730631T AT07730631T ATE485047T1 AT E485047 T1 ATE485047 T1 AT E485047T1 AT 07730631 T AT07730631 T AT 07730631T AT 07730631 T AT07730631 T AT 07730631T AT E485047 T1 ATE485047 T1 AT E485047T1
Authority
AT
Austria
Prior art keywords
growth
stimulating protein
preventing
treating
individual
Prior art date
Application number
AT07730631T
Other languages
English (en)
Inventor
Jukka Westermarck
Pietri Puustinen
Melissa Junttila
Original Assignee
Jukka Westermarck
Pietri Puustinen
Melissa Junttila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jukka Westermarck, Pietri Puustinen, Melissa Junttila filed Critical Jukka Westermarck
Application granted granted Critical
Publication of ATE485047T1 publication Critical patent/ATE485047T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
AT07730631T 2006-03-16 2007-03-14 Verwendung eines wachstumsstimulierenden proteins ATE485047T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20060246A FI20060246A0 (fi) 2006-03-16 2006-03-16 Uusi kasvua stimuloiva proteiini ja sen käyttö
PCT/FI2007/050137 WO2007104835A1 (en) 2006-03-16 2007-03-14 Use of a growth-stimulating protein

Publications (1)

Publication Number Publication Date
ATE485047T1 true ATE485047T1 (de) 2010-11-15

Family

ID=36191923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07730631T ATE485047T1 (de) 2006-03-16 2007-03-14 Verwendung eines wachstumsstimulierenden proteins

Country Status (11)

Country Link
US (3) US20090232821A1 (de)
EP (2) EP2004202B1 (de)
JP (1) JP5139332B2 (de)
CN (1) CN101443022B (de)
AT (1) ATE485047T1 (de)
CA (1) CA2646898A1 (de)
DE (1) DE602007009950D1 (de)
DK (1) DK2229946T3 (de)
ES (1) ES2429131T3 (de)
FI (1) FI20060246A0 (de)
WO (1) WO2007104835A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20060246A0 (fi) * 2006-03-16 2006-03-16 Jukka Westermarck Uusi kasvua stimuloiva proteiini ja sen käyttö
EP2129688A4 (de) * 2007-02-01 2010-03-24 Univ Florida Zusammensetzungen und verfahren zur krebserkennung
CN101664550A (zh) * 2008-09-07 2010-03-10 苏州爱生基因有限公司 治疗或预防癌症的方法和药物
FI20115876A0 (fi) 2011-09-06 2011-09-06 Turun Yliopisto Yhdistelmähoito
CN103484463A (zh) * 2013-09-12 2014-01-01 四川大学 一种沉默人c2orf68基因的shRNA及其医药用途
WO2016203118A1 (en) * 2015-06-18 2016-12-22 Turun Yliopisto Crystal structures of cip2a
WO2019097122A1 (en) * 2017-11-20 2019-05-23 Turun Yliopisto A novel cip2a variant and uses thereof
CN111549033B (zh) * 2020-06-11 2021-02-12 南京市江宁医院 慢病毒感染人表皮角质细胞株及其构建方法和应用
GB202417594D0 (en) * 2024-11-29 2025-01-15 Imperial College Innovations Ltd Cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080023768A (ko) * 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체
US20030190635A1 (en) 2002-02-20 2003-10-09 Mcswiggen James A. RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
CN100523215C (zh) * 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
EP1386004A4 (de) 2001-04-05 2005-02-16 Ribozyme Pharm Inc Modulation der mit der entzündungsausbreitung und dem neuritenauswuchs assoziierten genexpression unter verwendung von technologien auf nukleinsäurebasis
US20040019001A1 (en) 2002-02-20 2004-01-29 Mcswiggen James A. RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
US20030175950A1 (en) 2001-05-29 2003-09-18 Mcswiggen James A. RNA interference mediated inhibition of HIV gene expression using short interfering RNA
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
EP1658304A4 (de) 2002-09-28 2009-01-14 Massachusetts Inst Technology Mittel zur behandlung von grippe
EP2305813A3 (de) * 2002-11-14 2012-03-28 Dharmacon, Inc. Funktionale und hyperfunktionale siRNA
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20050043266A1 (en) 2003-07-25 2005-02-24 Sumedha Jayasena Short interfering RNA as an antiviral agent for hepatitis C
CA2566286A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
FI20060246A0 (fi) * 2006-03-16 2006-03-16 Jukka Westermarck Uusi kasvua stimuloiva proteiini ja sen käyttö

Also Published As

Publication number Publication date
WO2007104835A1 (en) 2007-09-20
US20090232821A1 (en) 2009-09-17
EP2004202A1 (de) 2008-12-24
DE602007009950D1 (de) 2010-12-02
EP2229946A3 (de) 2011-01-19
FI20060246A0 (fi) 2006-03-16
JP2009530593A (ja) 2009-08-27
EP2229946A2 (de) 2010-09-22
ES2429131T3 (es) 2013-11-13
EP2004202A4 (de) 2009-11-11
DK2229946T3 (da) 2013-10-14
CN101443022B (zh) 2012-05-30
US8410072B2 (en) 2013-04-02
US20120077750A1 (en) 2012-03-29
CN101443022A (zh) 2009-05-27
JP5139332B2 (ja) 2013-02-06
US20130197063A1 (en) 2013-08-01
US9062309B2 (en) 2015-06-23
EP2004202B1 (de) 2010-10-20
EP2229946B1 (de) 2013-08-14
CA2646898A1 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
DE602007009950D1 (de) Verwendung eines wachstumsstimulierenden proteins
EA200870289A1 (ru) Теплица, обшивка теплицы, фильтровальное устройство, осветительное устройство, направляющее устройство, применение и загрузочное устройство
ATE473630T1 (de) Verfahren zur bekämpfung von pflanzenkrankheitsschäden durch verwendung eines bacillus
DE602006014026D1 (de) Zusammensetzungen und verfahren zur regulierung eines komplementsystems
NZ590550A (en) Inhibitors of Apoptosis (IAP) for treating cancer
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
ATE538095T1 (de) Verfahren zur herstellung von 2-substituierten 5- (1-alkylthio)-alkylpyridinen
DK2005162T3 (da) Screeningsmetode
EA201100874A1 (ru) Соединения для лечения рака
ATE423663T1 (de) Einheit zur behandlung von pellets
DE602006020269D1 (en) Neue 2-pyridinylcycloalkylcarboxamid-derivate als fungizide
EP2333076A3 (de) Lebensmittel mit niedrigen Acrylamidwerten
MX2009007494A (es) Composicion fitosanitaria.
CY1118101T1 (el) Φορεας κυτταρων που περιεχει κολλαγονο
ATE380862T1 (de) Verfahren zur entgiftung von mykotoxinen
CY1118208T1 (el) Μεθοδος βιολογικου ελεγχου της λιστερια
DE602007006541D1 (de) Verwendung von wassergräsern als träger für erdbodenlose kultivierung und so gebildeter träger
ATE487487T1 (de) Verwendung von verbindungen, die die ef-tu- nucleolin wechselwirkung vehindern, zur verhinderung oder behandlung von tularämie
EA200900425A1 (ru) Способ повышения толерантности растений
ATE420075T1 (de) Neue heterocyclylethylbenzamidderivate
ATE510540T1 (de) Thioxanthen-derivate als alleinvertreter der antiinfektiva zur verwendung in der behandlung von infektionskrankheiten
TW200716132A (en) Novel chemical compounds
DE602005027322D1 (de) Verwendung von antikörpern gegen tweak zur behandlung von schlaganfall
ATE443991T1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
ATE507222T1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon- derivate zur verwendung als h3-modulatoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties